Related Experiment Video
Updated: Feb 8, 2026

Identification of Growth Inhibition Phenotypes Induced by Expression of Bacterial Type III Effectors in Yeast
Published on: March 30, 2010
Ellagic acid and Sennoside B inhibit osteosarcoma cell migration, invasion and growth by repressing the expression of
Wei Xu1, Jinjin Xu2, Ting Wang1
1Department of Orthopedic Oncology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.
Abstract:
Osteosarcoma is a mesenchymally derived, high-grade bone sarcoma that is the most frequently diagnosed primary malignant bone tumor. Today, chemoprevention is regarded as a promising and realistic approach in the prevention of human cancer. Previous studies have suggested ellagic acid (EA) and Sennoside B have potential in this regard. The aim of the present study was to elucidate the anti-osteosarcoma effects of EA and Sennoside B by using Saos-2 and MG63 osteosarcoma cells. It was identified that EA or Sennoside B treatment could inhibit the growth, migration and invasion of the cells, and induce G1 cell cycle arrest by repressing the transcription of c-Jun. These results may provide a cellular basis for the application of EA or Sennoside B in the treatment of patients with osteosarcoma.
Insights
Ellagic acid (EA) and Sennoside B show potential in preventing osteosarcoma. These compounds inhibit cancer cell growth, migration, and invasion, offering a cellular basis for their therapeutic application.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Osteosarcoma is a prevalent primary malignant bone tumor.
- Chemoprevention presents a promising strategy for human cancer prevention.
- Ellagic acid (EA) and Sennoside B have demonstrated potential chemopreventive properties.
Purpose of the Study:
- To investigate the anti-osteosarcoma effects of Ellagic acid (EA) and Sennoside B.
- To elucidate the mechanisms underlying the effects of EA and Sennoside B on osteosarcoma cells.
Main Methods:
- Utilized Saos-2 and MG63 osteosarcoma cell lines.
- Assessed the impact of EA and Sennoside B on cell growth, migration, and invasion.
- Analyzed cell cycle progression and c-Jun gene transcription.
Main Results:
- EA and Sennoside B significantly inhibited osteosarcoma cell growth, migration, and invasion.
- Treatment with EA or Sennoside B induced G1 cell cycle arrest.
- These effects were associated with the repression of c-Jun transcription.
Conclusions:
- EA and Sennoside B exhibit significant anti-osteosarcoma activity.
- The compounds inhibit key cancer cell behaviors and induce cell cycle arrest.
- Findings support the potential use of EA and Sennoside B in osteosarcoma treatment.
Related Concept Videos
Cell Migration
Cell Migration
Repressed Memory
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
Feedback Inhibition
Cancer Cell Migration through Invadopodia

